ID: h-1b47a73770
Hypothesis

APOE4-driven lysosome-to-ER cholesterol transport failure reduces ER-accessible cholesterol and releases SCAP-SREBP2 from ER retention

The strongest synthesis is an indirect mechanism in glia: APOE4 promotes cholesterol sequestration in late endosome/lysosome compartments, lowering the ER-accessible cholesterol pool sensed by SCAP despite normal or elevated total cellul.
🧬 NPC1🩺 molecular-biology🎯 Composite 74%💱 $0.59▼14.0%proposed
molecular biology
EvidencePending (0%)📖 0 cit🗣 1 debates 4 support 3 oppose
✓ All Quality Gates Passed
Mechanistic 0.84 (15%) Evidence 0.79 (15%) Novelty 0.63 (12%) Feasibility 0.78 (12%) Impact 0.71 (12%) Druggability 0.58 (10%) Safety 0.42 (8%) Competition 0.68 (6%) Data Avail. 0.75 (5%) Reproducible 0.72 (5%) KG Connect 0.50 (8%) 0.741 composite

🧪 Overview

The strongest synthesis is an indirect mechanism in glia: APOE4 promotes cholesterol sequestration in late endosome/lysosome compartments, lowering the ER-accessible cholesterol pool sensed by SCAP despite normal or elevated total cellular cholesterol. This weakens SCAP-INSIG retention, increases SREBP2 processing, and may explain the paradox of cholesterol accumulation alongside increased cholesterol biosynthesis.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["NPC1 Protein<br/>Intracellular Cholesterol Transporter"]
    B["NPC1 Mutation<br/>Lysosomal Cholesterol Accumulation"]
    C["Late Endosome Maturation<br/>Esterified Cholesterol Trapped"]
    D["ER Calcium Dysregulation<br/>Store-Operated Entry"]
    E["Mitochondrial Cholesterol<br/>Mitochondrial Membrane Rigid"]
    F["Apoptosis Susceptibility<br/>Increased Neuronal Death"]
    G["Axonal Transport Deficit<br/>Microtubule Disruption"]
    H["Neurodegeneration<br/>Neuronal Loss in NPC Disease"]
    I["Cognitive Decline<br/>Neurofibrillary Tangles"]
    A --> B
    B --> C
    C --> D
    D --> E
    E --> F
    F --> G
    G --> H
    H --> I
    style A fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
    style I fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix4 supports3 contradicts
Supports
APOE4 glia show lysosomal cholesterol accumulation and altered cholesterol homeostasis consistent with compartmental misrouting rather than simple cholesterol deficiency.
Supports
Recent data support APOE4-associated cholesterol sequestration and glial lipid trafficking defects relevant to ER sterol sensing.
Supports
ER-accessible cholesterol is the key regulatory pool controlling SCAP-SREBP retention and SREBP activation.
Supports
NPC-like lysosomal export failure is known to impair ER feedback and sustain SREBP activation.
Contradicts
No study directly demonstrates the full APOE4-to-NPC1/ER-contact-to-SCAP causal chain in human glia.
Contradicts
Lysosomal cholesterol accumulation could be secondary to broader autophagy or stress defects rather than the primary driver of SREBP2 activation.
Contradicts
Therapeutic cholesterol mobilizers such as cyclodextrins are pleiotropic and carry significant safety liabilities including ototoxicity risk.
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — NPC1

No curated PDB or AlphaFold mapping for NPC1 yet. Search RCSB →

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for NPC1 from GTEx v10.

Spinal cord cervical c-142.6 Substantia nigra14.4 Hippocampus13.7 Putamen basal ganglia11.6 Caudate basal ganglia10.3 Hypothalamus9.3 Amygdala9.2 Cerebellum8.5 Frontal Cortex BA98.3 Cerebellar Hemisphere8.1 Cortex7.9 Nucleus accumbens basal ganglia6.9 Anterior cingulate cortex BA246.6median TPM (GTEx v10)

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for NPC1 →

No DepMap CRISPR Chronos data found for NPC1.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

💰 Estimated Development
Cost
$0
Timeline

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Falling
7d Momentum
▼ 1.3%
Volatility
Low
0.0109
Events (7d)
3
Price History
▼14.0%

💾 Resource Usage

LLM Tokens
17,104
$0.0513
Total Cost
$0.0513

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF ER-localized cholesterol is measured directly using an ER-targeted cholesterol biosensor (ER-CholeMIM) in live APOE4 versus APOE3 astrocytes, THEN APOE4 astrocytes will exhibit ≥35% lower ER cholesER cholesterol concentration significantly lower in APOE4 (≥35% reduction); total cellular cholesterol unchanged between genotypes— no observation —pending0.68
IF cyclodextrin-mediated enhancement of cytosolic cholesterol trafficking to the ER is applied to APOE4 homozygous iPSC-derived astrocytes, THEN SREBP2 cleavage (nuclear SREBP2/total SREBP2 ratio) wilnuclear SREBP2 protein levels decrease ≥40%; HMG-CoA reductase activity normalized to APOE3 baseline— no observation —pending0.72
🔮 Falsifiable Predictions (2)
pendingconf 72%
IF cyclodextrin-mediated enhancement of cytosolic cholesterol trafficking to the ER is applied to APOE4 homozygous iPSC-derived astrocytes, THEN SREBP2 cleavage (nuclear SREBP2/total SREBP2 ratio) will decrease by ≥40% within 6 hours post-treatment, and total HMG-CoA reductase activity will normaliz
Predicted outcome: nuclear SREBP2 protein levels decrease ≥40%; HMG-CoA reductase activity normalized to APOE3 baseline
Falsification: SREBP2 processing remains elevated (change <20%) or increases further despite enhanced cholesterol delivery to the cytosol, indicating the transport defect is downstream of cytosolic redistribution
pendingconf 68%
IF ER-localized cholesterol is measured directly using an ER-targeted cholesterol biosensor (ER-CholeMIM) in live APOE4 versus APOE3 astrocytes, THEN APOE4 astrocytes will exhibit ≥35% lower ER cholesterol concentration despite no difference in total cellular cholesterol content, with this differenc
Predicted outcome: ER cholesterol concentration significantly lower in APOE4 (≥35% reduction); total cellular cholesterol unchanged between genotypes
Falsification: ER cholesterol concentration is equal or higher in APOE4 versus APOE3 cells, or NPC1 overexpression fails to increase ER cholesterol in APOE4 cells, disproving the lysosomal sequestration mechanism
Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
sourcev1_phase_c_backfill
origin_typedebate_synthesizer
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.